Keyphrases
Diabetic Macular Edema
100%
Visual Acuity
100%
Avastin
100%
Intravitreal Bevacizumab
100%
Retinal Thickness
71%
Previous Treatment
57%
Optical Coherence Tomography
42%
Intravitreal Injection
42%
ETDRS
42%
Bevacizumab
28%
Laser Therapy
28%
Vitrectomy
28%
Triamcinolone
28%
Treatment Recommendations
14%
San Francisco
14%
Consecutive Patients
14%
Inclusion Criteria
14%
Edema
14%
Control Types
14%
Mean Diameter
14%
Diabetes Management
14%
After Injection
14%
Treatment Group
14%
Short-term Outcomes
14%
Long Follow-up
14%
Informed Consent
14%
Specific Treatment
14%
Patient-completed
14%
Metabolic Control
14%
Diabetes Type 1
14%
Genentech
14%
Fluorescein Angiography
14%
Macula
14%
Foveal Avascular Zone
14%
Biomicroscopy
14%
Slit Lamp Examination
14%
Best-corrected Visual Acuity
14%
Intravitreal Ranibizumab
14%
Intraocular Pressure Measurement
14%
Photocoagulation
14%
Fundus Photography
14%
Eye Examination
14%
Baseline Visual Acuity
14%
Retinal Thickness Measurement
14%
Focal Laser
14%
Medicine and Dentistry
Diabetic Macular Edema
100%
Visual Acuity
100%
Bevacizumab
100%
Intravitreal Administration
50%
Optical Coherence Tomography
37%
Low Level Laser Therapy
25%
Vitrectomy
25%
Triamcinolone
25%
Diabetes
12%
Prospective Study
12%
Informed Consent
12%
Metabolic Regulation
12%
Fluorescein Angiography
12%
Ultrasound Biomicroscopy
12%
Slit Lamp Microscopy
12%
Laser Coagulation
12%
Best Corrected Visual Acuity
12%
Fundus Photography
12%
Retina Edema
12%
Macula of Retina
12%
Eye Examination
12%
Intraocular Pressure
12%
Treatment Group
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
100%
Diabetic Macular Edema
100%
Intravitreal Administration
66%
Triamcinolone
33%
Prospective Study
16%
Retina Edema
16%
Fluorescein
16%
Treatment Group
16%